Medigen Biotechnology Corp.

  • About Us
    • About Us
    • History
    • Corporate Milestones
    • Leadership
  • R&D
    • Clinical Trials
    • R&D Achievements
    • Collaborations
    • Subsidiaries
  • News
    • Press Releases
    • Events
  • ESG
  • Investors
    • Corporate Governance
    • Financials
    • Shareholder Services
    • Material Information
    • FAQs
  • Careers
    • Join Us
    • Learning and Development
    • Compensation and Benefits
    • Sustainable Talents
  • Contact
  • 繁體中文
  • 簡體中文
  • English

Press Releases

  • 2025/04/23 Los Angeles Times Interview with Medigen BioMedical Group Chairman Dr. Stanley Chang MORE
  • 2024/09/11 Medigen Receives the 2024 “Best Cell & Gene Therapy Biopharma in APAC” Award MORE
  • 2024/08/23 Clarification Statement by Medigen and Its Subsidiary Yingshin Investment Co., Ltd. (Supplement) MORE
  • 2024/08/21 Clarification Statement by Medigen and Its Subsidiary Yingshin Investment Co., Ltd. MORE
  • 2024/07/26 2024 BioAsia – Medigen Exhibits at Taipei Biotech Pavilion MORE
  • 2024/07/17 Medigen and CCH Apply to MOHW for Use of “GDT Cell” in Stage I–III Solid Tumors MORE
  • 2024/05/07 Medigen Biotechnology Corp. Participates in MOEA Taiwan Biotech Visiting Group to Japan MORE
  • 2024/01/10 Medigen and NKure in collaboration to develop Medigen's Magicell®-NK in India MORE
  • 2020/02/11 Medigen has obtained approval from Ministry of Health and Welfare for Natural Killer (NK) cell therapy MORE
  • 2019/12/09 MVC Teamed with US CDC to develop VLP Vaccine for Dengue Disease MORE
  • 1
  • 2
  • 3

About Us

  • About Us
  • History
  • Corporate Milestones
  • Leadership

R&D

  • Clinical Trials
  • R&D Achievements
  • Collaborations
  • Subsidiaries

News

  • Press Releases
  • Events

ESG

Investors

  • Corporate Governance
  • Financials
  • Shareholder Services
  • Material Information
  • FAQs

Careers

  • Join Us
  • Learning and Development
  • Compensation and Benefits
  • Sustainable Talents

Contact

  • Privacy Policy
  • Cookie Policy
Copyright © 2025 Medigen Biotechnology Corp. All Rights Reserved.